Atlas Trials

TAS-102 in Extrapulmonary Neuroendocrine Carcinoma

Clinical trial NCT04042714 · TERMINATED

Trial details

NCT number
NCT04042714
Sponsor
Baylor Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
High-grade Extra Pulmonary Neuroendocrine Cancer
Start date
2019-08-15
Primary completion
2025-09-15
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.